In ER-negative/PR-positive ERBB2-negative BC, a recent retrospective study32 found that patients who receive adjuvant endocrine therapy have statistically significantly longer relapse-free survival and OS than patients who do not receive endocrine therapy. Here, PGR is linked to breast cancer.